Search results
Results from the WOW.Com Content Network
The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs. It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980.
Psychedelic drugs, medicine: ... Psychedelic Medicine is a quarterly peer-reviewed medical journal on the use of serotonergic ... The journal was established in ...
His articles have appeared in many publications, including The Entheogen Review, The Entheogen Law Reporter, the Journal of Cognitive Liberties, the Journal of Psychoactive Drugs (AKA the Journal of Psychedelic Drugs), the MAPS Bulletin, Head, High Times, Curare, Eleusis, Integration, Lloydia, The Sacred Mushroom Seeker, and several Harvard ...
The following is a list of psychedelic drugs of various chemical classes, including both naturally occurring and synthetic compounds. Serotonergic psychedelics are usually considered the "classical" psychedelics [dubious – discuss], whereas the other classes are often seen as having only secondary psychedelic properties; nonetheless all of the compounds listed here are considered ...
Psychedelic drugs are useful for exploring the subconscious because a conscious sliver of the adult ego usually remains active during the experience. [25]: 196 Patients remain intellectually alert throughout the process and remember their experiences vividly afterward.
Psychedelic therapy involves the use of a hallucinogenic, perception-altering drugs coupled with psychotherapy to treat patients psychologically. The goal of the procedure was to unearth internal conflicts by administering LSD and then use therapy to resolve and work through these emerging latent conflicts.
The most well-known DOx drugs are DOM, DOI, DOB, DOET, and DOC. [3] DOI is widely used in scientific research. [2] [4] DOM has been used as a recreational drug, while DOET was an experimental pharmaceutical drug. [5] Most compounds of this class are potent and long-lasting psychedelic drugs, and act as selective 5-HT 2A, 5-HT 2B, and 5-HT 2C ...
[1] [4] [2] Charles Nichols is a professor and researcher at Louisiana State University School of Medicine and the lead scientist of the psychedelic medicine pharmaceutical company Eleusis Therapeutics (since acquired by Beckley Psytech). [1] [3] [5] He is also the co-editor-in-chief of the academic journal Psychedelic Medicine, which started ...